Economic impact of gastrointestinal medication reduction after conversion from mycophenolate mofetil (MMT) to enteric-coated mycophenolate sodium (EC-MPS).

被引：0
|
作者：
Bolin, Paul
Parker, Karen
Gerkin, Susan
机构：
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2007年 / 49卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
27
引用
收藏
页码：A31 / A31
页数：1
相关论文
共 50 条
  • [1] Economic impact of gastrointestinal medication reduction following conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) associated with improvement in quality of life (QOL)
    Parker, Karen R.
    Bolin, Paul
    Gerkin, Susan R.
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 350 - 350
  • [2] Enteric-coated mycophenolate sodium (EC-MPS) and mycophenolate mofetil (MMF), it is better to have the choice
    Budde, K
    Salvadori, M
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (05) : 1165 - 1166
  • [3] Conversion of Mycophenolate Mofetil (MMF) to Enteric-Coated Mycophenolate Sodium (EC-MPS) Ameliorates GI Symptoms in Liver Transplant Patients.
    de Vera, Michael E.
    Hope, Laurie
    Yelochan, Barbara
    Durant, Stephanie
    Lopez-Solis, Roberto
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 531 - 531
  • [4] CONVERSION OF MYCOPHENOLATE MOFETIL (MMF) TO ENTERIC COATED MYCOPHENOLATE SODIUM (EC-MPS) IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS
    Matsuda-Abedini, Mina
    Kiang, Tony K. L.
    Ensom, Mary H. H.
    [J]. PEDIATRIC TRANSPLANTATION, 2011, 15 : 131 - 131
  • [5] Enteric-coated mycophenolate sodium (EC-MPS) improves GI symptoms and immunosuppression in patients treated with mycophenolate mofetil (MMF)
    Sabbatini, Massimo
    Mirenghi, Francesco
    Caputo, Carmela
    Capone, Domenico
    Gentile, Antonio
    Polichetti, Giuliano
    Basile, Vincenzo
    Gallo, Riccardo
    Apicella, Luca
    Federico, Stefano
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 395 - 395
  • [6] Conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) results in reduction of severity of gastrointestinal adverse effects in long-term kidney allograft recipients
    Stolyarevich, Ekatherina
    Vedernikova, Raisa
    Tomilina, Natalya
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 126 - 126
  • [7] Reduction of Gastrointestinal Complications in Renal Graft Recipients after Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium
    Reinke, P.
    Budde, K.
    Hugo, C.
    Petersen, P.
    Schnuelle, P.
    Fricke, L.
    Scholz, D.
    Sperschneider, H.
    Bahner, U.
    Kramer, S.
    Fischer, W.
    Arns, W.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (05) : 1641 - 1646
  • [8] USE OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN LIVER TRANSPLANT PATIENTS
    de Vera, Michael E.
    Lopez, Roberto
    Yelochan, Barbara
    Hope, Laurie
    Marcos, Amadeo
    Fontes, Paulo
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S112 - S112
  • [9] Enteric-Coated Mycophenolate Sodium (EC-MPS) Has Less GI Side Effects and Similar Efficacy to Mycophenolate Mofetil (MMF)
    de Vera, Michael E.
    Hope, Laurie
    Kikla, Stephenie
    Durant, Stephanie
    Fedorek, Sheila
    Lopez, Roberto
    [J]. LIVER TRANSPLANTATION, 2010, 16 (06) : S182 - S182
  • [10] Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
    Kyle M. Gardiner
    Susan E. Tett
    Christine E. Staatz
    [J]. Drugs in R&D, 2018, 18 : 271 - 282
12345